Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.00001 par value
-
Shares outstanding
-
274,772,727
-
Total 13F shares
-
18,273,544
-
Share change
-
-1,083,660
-
Total reported value
-
$212,886,592
-
Price per share
-
$11.65
-
Number of holders
-
60
-
Value change
-
-$15,463,883
-
Number of buys
-
39
-
Number of sells
-
13
Institutional Holders of Taysha Gene Therapies, Inc. - Common Stock, $0.00001 par value (TSHA) as of Q4 2021
As of 31 Dec 2021 Taysha Gene Therapies, Inc. - Common Stock, $0.00001 par value (TSHA) had 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 18,273,544 shares of stock of the company.
Largest 10 holders included FMR LLC, BlackRock Inc., Nantahala Capital Management, LLC, FRANKLIN RESOURCES INC, UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO, Artal Group S.A., VANGUARD GROUP INC, Sands Capital Ventures, LLC, TimesSquare Capital Management, LLC, and Alphabet Inc..
This table shows 60 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.